Form 8-K - Current report:
SEC Accession No. 0001193125-23-014238
Filing Date
2023-01-24
Accepted
2023-01-24 16:30:01
Documents
13
Period of Report
2023-01-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d402822d8k.htm   iXBRL 8-K 26970
5 GRAPHIC g402822g0124054650865.jpg GRAPHIC 1904
  Complete submission text file 0001193125-23-014238.txt   154788

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ardx-20230118.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ardx-20230118_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ardx-20230118_pre.xml EX-101.PRE 11261
7 EXTRACTED XBRL INSTANCE DOCUMENT d402822d8k_htm.xml XML 3327
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 23548477
SIC: 2834 Pharmaceutical Preparations